Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study

Sonja Wurm; Jennifer M Moritz; Verena Petzer; Dominik Wolf; Karoline V Gleixner; Wolfgang R Sperr; Christina Groiss; Sigrid Machherndl-Spandl; Gregor Eisenwort; Elisabeth Koller; Johannes Schoeche; Clemens Petrasch; Josef Singer; Daniel M Mayer; Gudrun Pregartner; Annkristin Heine; Albert Wölfler; Heinz Sill; Andreas Reinisch; Armin Zebisch

doi:10.1038/s41408-025-01396-5

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study

Sonja Wurm
, Jennifer M Moritz
, Verena Petzer
, Dominik Wolf
, Karoline V Gleixner
, Wolfgang R Sperr
, Christina Groiss
, Sigrid Machherndl-Spandl
, Gregor Eisenwort
, Elisabeth Koller
, Johannes Schoeche
, Clemens Petrasch
, Josef Singer
, Daniel M Mayer
, Gudrun Pregartner
, Annkristin Heine
, Albert Wölfler
, Heinz Sill
, Andreas Reinisch
, Armin Zebisch

Division of Internal Medicine 2 (University Hospital Krems)

Research output: Journal article (peer-reviewed) › Letter/short communication

Original language	English
Article number	175
Pages (from-to)	175
Journal	Blood Cancer Journal
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41408-025-01396-5
Publication status	Published - Dec 2025

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-025-01396-5

Cite this

Wurm, S., Moritz, J. M., Petzer, V., Wolf, D., Gleixner, K. V., Sperr, W. R., Groiss, C., Machherndl-Spandl, S., Eisenwort, G., Koller, E., Schoeche, J., Petrasch, C., Singer, J., Mayer, D. M., Pregartner, G., Heine, A., Wölfler, A., Sill, H., Reinisch, A., & Zebisch, A. (2025). Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study. Blood Cancer Journal, 15(1), 175. Article 175. https://doi.org/10.1038/s41408-025-01396-5

@article{f1cb93fff75a42868640c9a20326209b,

title = "Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study",

author = "Sonja Wurm and Moritz, \{Jennifer M\} and Verena Petzer and Dominik Wolf and Gleixner, \{Karoline V\} and Sperr, \{Wolfgang R\} and Christina Groiss and Sigrid Machherndl-Spandl and Gregor Eisenwort and Elisabeth Koller and Johannes Schoeche and Clemens Petrasch and Josef Singer and Mayer, \{Daniel M\} and Gudrun Pregartner and Annkristin Heine and Albert W{\"o}lfler and Heinz Sill and Andreas Reinisch and Armin Zebisch",

year = "2025",

month = dec,

doi = "10.1038/s41408-025-01396-5",

language = "English",

volume = "15",

pages = "175",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "1",

}

Wurm, S, Moritz, JM, Petzer, V, Wolf, D, Gleixner, KV, Sperr, WR, Groiss, C, Machherndl-Spandl, S, Eisenwort, G, Koller, E, Schoeche, J, Petrasch, C, Singer, J, Mayer, DM, Pregartner, G, Heine, A, Wölfler, A, Sill, H, Reinisch, A & Zebisch, A 2025, 'Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study', Blood Cancer Journal, vol. 15, no. 1, 175, pp. 175. https://doi.org/10.1038/s41408-025-01396-5

TY - JOUR

T1 - Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents

T2 - a real-world, multicentric study

AU - Wurm, Sonja

AU - Moritz, Jennifer M

AU - Petzer, Verena

AU - Wolf, Dominik

AU - Gleixner, Karoline V

AU - Sperr, Wolfgang R

AU - Groiss, Christina

AU - Machherndl-Spandl, Sigrid

AU - Eisenwort, Gregor

AU - Koller, Elisabeth

AU - Schoeche, Johannes

AU - Petrasch, Clemens

AU - Singer, Josef

AU - Mayer, Daniel M

AU - Pregartner, Gudrun

AU - Heine, Annkristin

AU - Wölfler, Albert

AU - Sill, Heinz

AU - Reinisch, Andreas

AU - Zebisch, Armin

PY - 2025/12

Y1 - 2025/12

UR - https://www.scopus.com/pages/publications/105019597748

U2 - 10.1038/s41408-025-01396-5

DO - 10.1038/s41408-025-01396-5

M3 - Letter/short communication

C2 - 41125585

SN - 2044-5385

VL - 15

SP - 175

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

M1 - 175

ER -

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this